Inventor · disambiguated record
Corey R. Hopkins
Also filed as: HOPKINS COREY · HOPKINS COREY R
26 granted patents·6 pending applications·194 citations·filing 2003–2022
96Inventor score
Top patents by PatentIndex Score
32 records- 0192US9056876B2Substituted 1H-pyrazolo[3′,4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2012·Granted Jun 16, 2015·18 cites·11 claims
- 0291US9980945B2Benzoisoxazole-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2016·Granted May 29, 2018·8 cites·20 claims
- 0390US8822684B1Compounds and methods useful for directing stem cell differentiationHONG CHARLES C·Filed 2009·Granted Sep 2, 2014·14 cites·1 claims
- 0490US8759377B2Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2010·Granted Jun 24, 2014·15 cites·4 claims
- 0589US9108963B2Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2012·Granted Aug 18, 2015·12 cites·34 claims
- 0689US8916584B2Benzisoxazoles and azabenzisoxazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2011·Granted Dec 23, 2014·15 cites·34 claims
- 0788US9180192B2mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2010·Granted Nov 10, 2015·12 cites·16 claims
- 0888US9163015B2Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2011·Granted Oct 20, 2015·12 cites·31 claims
- 0988US9040694B1Compounds and methods useful for directing stem cell differentiationUNIV VANDERBILT·Filed 2014·Granted May 26, 2015·7 cites·16 claims
- 1088US8658650B2Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2010·Granted Feb 25, 2014·15 cites·41 claims
- 1187US10196392B2Fused heterocyclic compounds as selective BMP inhibitorsUNIV VANDERBILT·Filed 2017·Granted Feb 5, 2019·6 cites·15 claims
- 1287US9738636B2Fused heterocyclic compounds as selective BMP inhibitorsUNIV VANDERBILT·Filed 2013·Granted Aug 22, 2017·9 cites·8 claims
- 1387US9192603B2Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2011·Granted Nov 24, 2015·12 cites·24 claims
- 1487US8912336B2Aryl and heteroaryl sulfones as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2010·Granted Dec 16, 2014·12 cites·16 claims
- 1586US8779157B2MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionCONN P JEFFREY·Filed 2010·Granted Jul 15, 2014·12 cites·40 claims
- 1683US10526323B2Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2016·Granted Jan 7, 2020·2 cites·45 claims
- 1782US9586964B2Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2012·Granted Mar 7, 2017·4 cites·10 claims
- 1879US10710997B2Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2017·Granted Jul 14, 2020·1 cites·34 claims
- 1979US10227343B2Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2016·Granted Mar 12, 2019·3 cites·27 claims
- 2078US9073935B2Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2012·Granted Jul 7, 2015·2 cites·10 claims
- 2170US10221172B2Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionUNIV VANDERBILT·Filed 2016·Granted Mar 5, 2019·1 cites·19 claims
- 2265US10654847B2Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2018·Granted May 19, 2020·0 cites·20 claims
- 2364US2020231592A1Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1VANDERBILT UNVERSITY·Filed 2020·Application pending·0 cites
- 2459US2025009716A1Novel inhibitors of claudin-1 for therapeutic interventionsUNIV NEBRASKA·Filed 2022·Application pending·0 cites
- 2558US7132428B2Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disordersAVENTIS PHARMA INC·Filed 2003·Granted Nov 7, 2006·2 cites·5 claims
- 2656US11180499B2Phosphodiesterase inhibitorsUNIV NEBRASKA·Filed 2021·Granted Nov 23, 2021·0 cites·19 claims
- 2756US2017129889A1Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1UNIV VANDERBILT·Filed 2017·Application pending·0 cites
- 2844US10745400B2Inhibition of BMP signaling, compounds, compositions and uses thereofUNIV VANDERBILT·Filed 2019·Granted Aug 18, 2020·0 cites·17 claims
- 2943US2020054643A1Fused heterocyclic compounds as selective bmp inhibitorsUNIV VANDERBILT·Filed 2018·Application pending·0 cites
- 3042US11370769B2TRPC5 inhibitors and methods of using sameUNIV NEBRASKA·Filed 2018·Granted Jun 28, 2022·0 cites·14 claims
- 3140US2019218214A1Inhibition of BMP Signaling Compounds, Compositions and Uses ThereofUNIV VANDERBILT·Filed 2017·Application pending·0 cites
- 3236US2012184556A1Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiatorsCONN P JEFFREY·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →